Drug Use During Sex and Its Impact on Taking PrEP (Pre-Exposure Prophylaxis) : CONSUME

NCT04709016 | Completed DMC

• 1 other identifier: 2020-A02182-37
• Study Type: observational
• Target: 100
• Locations: 1 country
• Sites: 1

Brief Summary

This is a cross-sectional, single-center observational study conducted from October 2020 to March 2021 in Ile de France at the infectious disease of CHU Bichat (PrEP and CeGIDD(Free Center for Information, Screening and Diagnosis of Infections by Human Immunodeficiency Viruses, Viral Hepatitis and Sexually Transmitted Infections) consultation). It concerns adult subjects of male or transgender sex, of MSM (men having sex with men) or bi-sexual orientation. The data are collected by self-questionnaire evaluating the consumption of Chemsex (drug use in a sexual context) over the last 12 months, the existence or not of addiction treatment, the history of STIs (sexually transmitted infections) and adherence to PrEP (for subjects taking PrEP) during the last sexual intercourse (ANRS questionnaire, used in the PREVENIR study).

Conditions

Drug Dependence

Keywords

Chemsex; PrEP

Outcome Measures

Primary Outcomes (1)

• compare in an MSM and transgender population, the use of Chemsex depending on whether or not PrEP is taken

  inclusion

Secondary Outcomes (3)

• Reported adherence to PrEP

  inclusion

• The existence or not of psychological comorbidity and the existence of addictological care

  inclusion

• The number of sexually transmitted infections at inclusion

  inclusion

Study Arms (1)

male or transgender patients

of sexual orientation MSM (men having sex with men) or bi-sexual, consultant in sexual health centers

Behavioral: self-questionnaire

Interventions

self-questionnaire BEHAVIORAL

self-questionnaire assessing Chemsex's (drug use in a sexual context) consumption over the last 12 months

male or transgender patients

Eligibility Criteria

• Age: 18 Years+
• Gender Eligibility Details: male or transgender MSM or bi-sexual orientation
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

The study concerns subjects of male or transgender sex, of MSM or bi-sexual sexual orientation, consulting in sexual health centers.

You may qualify if:

• age\> 18
• male or transgender
• MSM or bi-sexual orientation
• adult consultant at Bichat Hospital (CeGIDD or PrEP consultation)
• adult with a Smartphone (online self-questionnaire)

You may not qualify if:

• For the group "taking PrEP": adult taking PrEP for less than 3 months
• Refusal of participation

Sponsors & Collaborators

• Assistance Publique - Hôpitaux de Paris: lead

Study Sites (1)

SMIT - Hôpital Bichat

Paris, 75018, France

Location

MeSH Terms

Conditions

Substance-Related Disorders; Chemsex

Condition Hierarchy (Ancestors)

Chemically-Induced Disorders; Mental Disorders; Sexual Behavior; Behavior

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 7, 2021
• First Posted: January 14, 2021
• Study Start: March 18, 2021
• Primary Completion: March 25, 2022
• Study Completion: March 25, 2022
• Last Updated: August 30, 2022

Record last verified: 2021-05

Data Sharing

• IPD Sharing: Will not share

Locations

FR (1)